333 related articles for article (PubMed ID: 10971698)
21. A comparative immunohistochemical study of malignant mesothelioma and renal cell carcinoma: the diagnostic utility of Leu-M1, Ber EP4, Tamm-Horsfall protein and thrombomodulin.
Attanoos RL; Goddard H; Thomas ND; Jasani B; Gibbs AR
Histopathology; 1995 Oct; 27(4):361-6. PubMed ID: 8847067
[TBL] [Abstract][Full Text] [Related]
22. Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases.
DeLong W; Grignon DJ; Eberwein P; Shum DT; Wyatt JK
Arch Pathol Lab Med; 1993 Jun; 117(6):636-40. PubMed ID: 7684893
[TBL] [Abstract][Full Text] [Related]
23. Spindle cell tumours of the pleura: a clinical, histological and comparative genomic hybridization analysis of 14 cases.
Knuuttila A; Jee KJ; Taskinen E; Wolff H; Knuutila S; Anttila S
Virchows Arch; 2006 Feb; 448(2):135-41. PubMed ID: 16170537
[TBL] [Abstract][Full Text] [Related]
24. 'Pseudomesotheliomatous' carcinomas of the pleura: a 10-year analysis of cases from the Environmental Lung Disease Research Group, Cardiff.
Attanoos RL; Gibbs AR
Histopathology; 2003 Nov; 43(5):444-52. PubMed ID: 14636270
[TBL] [Abstract][Full Text] [Related]
25. Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma.
Comin CE; Novelli L; Boddi V; Paglierani M; Dini S
Hum Pathol; 2001 May; 32(5):529-36. PubMed ID: 11381372
[TBL] [Abstract][Full Text] [Related]
26. The diagnostic utility of immunohistochemistry in distinguishing between epithelioid mesotheliomas and squamous carcinomas of the lung: a comparative study.
Ordóñez NG
Mod Pathol; 2006 Mar; 19(3):417-28. PubMed ID: 16415794
[TBL] [Abstract][Full Text] [Related]
27. [Expression of cytokeratin 5 and calretinin in clear-cell renal cell carcinoma].
Cid Mouteira P; Ortiz-Rey JA; Gómez de Maria C; San Miguel Fraile P; Albor Barroso A; Regueiro Parcero B; Antón Badiola I
Actas Urol Esp; 2006 Apr; 30(4):367-71. PubMed ID: 16838608
[TBL] [Abstract][Full Text] [Related]
28. Frequent expression of conventional endothelial markers in pleural mesothelioma: usefulness of claudin-5 as well as combined traditional markers to distinguish mesothelioma from angiosarcoma.
Nakashima Y; Inamura K; Ninomiya H; Okumura S; Mun M; Kirimura S; Kobayashi M; Okubo K; Ishikawa Y
Lung Cancer; 2020 Oct; 148():20-27. PubMed ID: 32777673
[TBL] [Abstract][Full Text] [Related]
29. Wilms tumor 1/cytokeratin dual-color immunostaining reveals distinctive staining patterns in metastatic melanoma, metastatic carcinoma, and mesothelial cells in pleural fluids: an effective first-line test for the workup of malignant effusions.
Conner JR; Cibas ES; Hornick JL; Qian X
Cancer Cytopathol; 2014 Aug; 122(8):586-95. PubMed ID: 25044880
[TBL] [Abstract][Full Text] [Related]
30. Immunoreactivity for calretinin and keratins in desmoid fibromatosis and other myofibroblastic tumors: a diagnostic pitfall.
Barak S; Wang Z; Miettinen M
Am J Surg Pathol; 2012 Sep; 36(9):1404-9. PubMed ID: 22531174
[TBL] [Abstract][Full Text] [Related]
31. [Sarcomatoid malignant mesothelioma: a clinicopathologic and immunohistochemical analysis of 22 cases].
Lao I; Chen Q; Yu L; Wang J
Zhonghua Bing Li Xue Za Zhi; 2014 Jun; 43(6):364-9. PubMed ID: 25208984
[TBL] [Abstract][Full Text] [Related]
32. The value of 'mesothelium-associated' antibodies in distinguishing between metastatic renal cell carcinomas and mesotheliomas.
Osborn M; Pelling N; Walker MM; Fisher C; Nicholson AG
Histopathology; 2002 Oct; 41(4):301-7. PubMed ID: 12383211
[TBL] [Abstract][Full Text] [Related]
33. Podoplanin is a better immunohistochemical marker for sarcomatoid mesothelioma than calretinin.
Padgett DM; Cathro HP; Wick MR; Mills SE
Am J Surg Pathol; 2008 Jan; 32(1):123-7. PubMed ID: 18162779
[TBL] [Abstract][Full Text] [Related]
34. HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma.
Naso JR; Tsuji S; Churg A
Am J Surg Pathol; 2020 Aug; 44(8):1143-1148. PubMed ID: 32205484
[TBL] [Abstract][Full Text] [Related]
35. Differential diagnosis of sarcomatoid mesothelioma from true sarcoma and sarcomatoid carcinoma using immunohistochemistry.
Kushitani K; Takeshima Y; Amatya VJ; Furonaka O; Sakatani A; Inai K
Pathol Int; 2008 Feb; 58(2):75-83. PubMed ID: 18199156
[TBL] [Abstract][Full Text] [Related]
36. Calretinin: a novel immunocytochemical marker for mesothelioma.
Doglioni C; Dei Tos AP; Laurino L; Iuzzolino P; Chiarelli C; Celio MR; Viale G
Am J Surg Pathol; 1996 Sep; 20(9):1037-46. PubMed ID: 8764740
[TBL] [Abstract][Full Text] [Related]
37. TLE1 expression in malignant mesothelioma.
Matsuyama A; Hisaoka M; Iwasaki M; Iwashita M; Hisanaga S; Hashimoto H
Virchows Arch; 2010 Nov; 457(5):577-83. PubMed ID: 20857142
[TBL] [Abstract][Full Text] [Related]
38. Calretinin staining pattern aids in the differentiation of mesothelioma from adenocarcinoma in serous effusions.
Chhieng DC; Yee H; Schaefer D; Cangiarella JF; Jagirdar J; Chiriboga LA; Jagirdar J; Chiriboga LA; Cohen JM
Cancer; 2000 Jun; 90(3):194-200. PubMed ID: 10896333
[TBL] [Abstract][Full Text] [Related]
39. Inhibin is more specific than calretinin as an immunohistochemical marker for differentiating sarcomatoid granulosa cell tumour of the ovary from other spindle cell neoplasms.
Shah VI; Freites ON; Maxwell P; McCluggage WG
J Clin Pathol; 2003 Mar; 56(3):221-4. PubMed ID: 12610103
[TBL] [Abstract][Full Text] [Related]
40. Immunohistochemical evidence for mesothelial origin of paratesticular adenomatoid tumour.
Delahunt B; Eble JN; King D; Bethwaite PB; Nacey JN; Thornton A
Histopathology; 2000 Feb; 36(2):109-15. PubMed ID: 10672054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]